From Evolution to Revolution: New Mechanisms of Action in Ulcerative Colitis

Recent advances in ulcerative colitis drug development have opened new therapeutic perspectives. This webinar brings together leading experts to discuss the latest phase 3 results with Obefazimod and explore future directions, including subgroup outcomes and combination therapy potential.